title: Thrombotic thrombocytopenic purpura in a patient treated with imatinib mesylate: true association or mere coincidence?
abstract: Thrombotic thrombocytopenic purpura (TTP), characterized by thrombocytopenia and microangiopathic hemolytic anemia, is a relatively rare disorder. The majority of cases have no defined causes. TTP has been reported in association with many drugs, but not with imatinib mesylate. We report a 22-year-old African-American woman who developed idiopathic hypereosinophilic syndrome. She was treated with imatinib mesylate and subsequently developed microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. TTP was diagnosed. A kidney biopsy was performed and was diagnostic of thrombotic microangiopathy. The patient was treated with plasma exchange and hemodialysis. Her eosinophilia resolved, but she remained dialysis dependent. To our knowledge, this is the first case report of the possible association between imatinib mesylate and TTP.
authors.affiliation: Division of Nephrology, Saint Louis University, Saint Louis, MO 63110, USA. zalaly@slu.edu
authors.forename: Ziyad
authors.initials: Z
authors.lastname: Al Aly
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Philoctête Ashley
authors.forename: Mary E
authors.initials: ME
authors.lastname: Gellens
authors.forename: Esther A
authors.initials: EA
authors.lastname: González
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy; D000328:Adult; D001549:Benzamides; D003131:Combined Modality Therapy; D005260:Female; D005335:Fever of Unknown Origin / Q000209:etiology; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000188:drug therapy; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008206:Lymphatic Diseases / Q000209:etiology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D006435:Renal Dialysis; D015356:Retinal Artery Occlusion / Q000209:etiology
chemical_list: D001549:Benzamides; D007166:Immunosuppressive Agents; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate